Robert Aspbury
Corporate Officer/Principal bij CERTARA, INC.
Vermogen: 5 M $ op 31-03-2024
Profiel
Robert P.
Aspbury is currently the President-Certara Scientific Software at Certara, Inc. Prior to his current position, he worked as the Vice President-Strategic Solutions at Labcorp Drug Development, Inc. from 2016 to 2019.
He holds a doctorate degree from The University of Liverpool, which he obtained in 1995.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CERTARA, INC.
0.18% | 01-04-2024 | 290 176 ( 0.18% ) | 5 M $ | 31-03-2024 |
Actieve functies van Robert Aspbury
| Bedrijven | Functie | Begin |
|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01-01-2020 |
Eerdere bekende functies van Robert Aspbury
| Bedrijven | Functie | Einde |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01-03-2019 |
Opleiding van Robert Aspbury
| The University of Liverpool | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
